Table 3.
Auction market calves | M. haemolytica isolates not susceptible on first test (%) (n = 116) | M. haemolytica isolates not susceptible on second test (%) (n = 44) | Prevalence of matched calves with M. haemolytica isolates not susceptible on first test (%) (n = 217) | Prevalence of matched calves with M. haemolytica isolates not susceptible on second test (%) (n = 217) | P-value for matched calvesa |
---|---|---|---|---|---|
Ampicillin | 0% | 0% | 0% | 0% | — |
Ceftiofur | 0% | 0% | 0% | 0% | — |
Danofloxacin | 0% | 0% | 0% | 0% | — |
Enrofloxacin | 0% | 0% | 0% | 0% | — |
Florfenicol | 0% | 0% | 0% | 0% | — |
Oxytetracycline | 26.7% | 52.3% | 10.6% | 10.6% | 0.99 |
Penicillin | 1.7% | 2.3% | 0% | 0.5% | 0.99 |
Tilmicosin | 27.6% | 50% | 11.1% | 10.1% | 0.76 |
Tulathromycin | 4.3% | 36.4% | 1.4% | 7.4% | 0.006 |
| |||||
Ranch-raised calves | M. haemolytica isolates not susceptible on first test (%) (n = 79) | M. haemolytica isolates not susceptible on second test (%) (n = 57) | Prevalence of matched calves with M. haemolytica isolates not susceptible on first test (%) (n = 279) | Prevalence of matched calves with M. haemolytica isolates not susceptible on second test (%) (n = 279) | P-value for matched calvesa |
| |||||
Ampicillin | 0% | 0% | 0% | 0% | — |
Ceftiofur | 0% | 0% | 0% | 0% | — |
Danofloxacin | 0% | 0% | 0% | 0% | — |
Enrofloxacin | 1.3% | 0% | 0.4% | 0% | 0.99 |
Florfenicol | 0% | 0% | 0% | 0% | — |
Oxytetracycline | 20.3% | 1.8% | 5.7% | 0.4% | 0.005 |
Penicillin | 0% | 8.8% | 0% | 1.8% | 0.06 |
Tilmicosin | 19.0% | 0% | 5.4% | 0% | 0.001 |
Tulathromycin | 19.0% | 0% | 5.4% | 0% | 0.001 |
Calves with both a first test and a second test sample collected were designated as test matched.